Related Experiment Video
Updated: Aug 18, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 16, 2013
Combined use of astemizole and ketoconazole resulting in torsade de pointes
1Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan ROC.
Abstract:
Torsade de pointes is a serious ventricular arrhythmia which is usually associated with a long QT interval. It is important to recognize the possible predisposing factors for the management of this arrhythmia. Prolongation of the QT interval and torsade de pointes has been reported in patients with an overdose of astemizole. We report on a 63-year-old woman presenting with torsade de pointes and a long QT interval caused by the combined use of astemizole (at recommended dosage), and ketoconazole. After discontinuation of these drugs and treatment with a temporary pacemaker, magnesium sulfate and lidocaine, the arrhythmia was no longer observed and she was discharged in good condition with a normal electrocardiogram. This case should alert clinicians to the possibility of torsade de pointes with the combined use of astemizole and ketoconazole.
Related Concept Videos
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

